neuropharm Flashcards
benzoz
diazepam, lorazepam,triazolam, temazepam, omaxepam,midazolam, chlordiazepoxide,alprazolam
mechanism:facilitates GABA action by inc frequency of cl channel opening , dec REM sleep,
most have long half lives and active metabolites ATOM
alprazolam triazolam oxazepam midazolam are short acting - higher additive potential
clinical use of benzos
anxiety ,panic disorder, spasticity , status eplipticus ,eclapmsia , detoxification ,night terrors ,sleep walking ,general anesthetic ,hypnotic ,lorazepam ,oxazepam, temazpam ,, can be used in those with liver disease who drink aLOT due to minimal first pass metabolism
adverse effects
dependance ,additive cns depression effects with alchohol and barbiturates ,less respiratory depression and coma than with barbiturates
treat over dose with flumazenil (competitive antagonist at GABA benzodiazepine receptor, can precipitate seizures by causing acute benzodiazpepine withdrawl
barbiturates
phenibarbital ,pentibarbital ,thiopental ,secobarbital
facilitate GABA action by inc duration of cl channel opening thus dec neuron firing
sedative for anxiety seizures insomnia ,induction of anesthesia
barbiturates
phenibarbital ,pentobarbital ,thiopental ,secobarbital
facilitate GABA action by inc duration of cl channel opening thus dec neuron firing
sedative for anxiety seizures insomnia ,induction of anesthesia
adverse effects of barbiturates
resp and cvs depression ,can be fatal ,cns depression,can be exacerbated by alchohol use , dependence, drug interactions ,induces cytochrome p450
overdose treatment is supportive, assist respiration and maintain bp
contraindicated in porphyria
insomnia therapy non benzo hypnotics
zolpidem ,zaleplon ,eszopiclone ,act via bz1 subtype of gaba receptor
a/e
ataxia, headaches ,confusion ,,casue only modest day after pyshcomotor depression and few amnestic effects ,vs older sedative hypnotics
short duration due to rapid metabolism by liver enzymes
effects reversed by flumazenil
dec dependency risk and sleep cycle disturbance
suvorexant ,ramelteon
orexin ,receptor antagonist ,cns depression ,headache,abnormal sleep related activities
contraindications: narcolepsy combination with strong cyp3a4 inhibitors
not recommended in pts with liver disease
limited risk
ramelteon ,melatonin recceptor agonist ,binds ,mlt1 and mlt2 in suprachiasmatic nuclues ,
dizziness ,nausea ,fatigue ,headache
no known risk of dependency
sumatriptan
5ht ib/id agonist
inhibit trigeminal nerve activation , prevent vasoactive peptide release ,induce vasoconstriction
acute migraine ,cluster headache attacks
coronary vasospasm
ce with pts with cad vasospastic angina ,mild paresthesia ,serotonin syndrome
non ergot dopamine agonist
pramipexole ,ropinirole
toxicity nausea ,impulse control disorder,hypotension ,confusion ,
ergot, bromocriptine rarely used toxic
inc dopamine availability amantidine
inc dopamine release dec reuptake ,= peripheral edema ,livedo reticularis ,ataxia
inc L- dopa availability
agents that prevent peripheral pre (bbb) l dopa degradation ,inc l dopa entering in cns ,inc central l dopa available for conversion into dopamine ,n/v
entacapone and tolcapone ,prevents peripheral l dopa degradation to 3-0-methyldopa by inhibiting comt ,used in conjugation with levodopa
prevent dopamine breakdown
agents that act centrally post bbb
selegiline ,rasagiline ,block conversion of dopamine to dopac by selectively inhibiting MAO-b
tolcapone ,crosses bbb and blocks conversion of dopamine to 3mt by inhibiting central comt
curb excess cholinergic activity
benzotropine trihexyphenidyl ,improves tremor and rigidity no effect on bradykinesia
alzheimer disease
donepezil ,rivastigmine galantamine ache inhibitor 1st line treatment n/dizziness contraindicated in pts with cardiac conduction abnormalities
memantine
nmda receptor antagonist helps prevent excitotoxicity used for moderate to advanced dementia a/e dizziness,confusion hallucination
als
riluzole, dec neuron glutamate excitotoxicity
inc survival
huntington
tetrabenzine ,
inhibit vesicular ,monoamine transporter,vmat
dec dopamine vesicle packaging and release ,huntington chorea and tardive dyskinesia
desflurane,halothane,enflurane,isoflurane,sevoflurane,methoxyflurane,n20
myocardial depression ,respiratory depression ,post op n/v ,cerebral blood flow inc, inc icp ,dec cerebral metabolic demand
hepatotoxicity ,halothane, nephrotoxicity methoxyflurane,proconvulsant,enflurane ,epliptogenic ,expansion of trapped gas in body cavity 3